Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
tac01-cd19 (1 trial)
tac01-cldn18.2 (1 trial)
tac01-her2 (1 trial)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Trials (3 total)
Trial APIs (3 total)